Protocol : BPC-157: 500 mcg/day (near injury or systemic) CJC-1295 w/ DAC: 2 mg twice per week Ipamorelin: 100200 mcg, 12x/day Duration: 68 weeks max Stacking Summary Potential Side Effects and Safety Profile of BPC-157 Compared to most performance-enhancing drugs, peptides, or even over-the-counter recovery aids, BPC-157 is remarkably well-tolerated
After 72 h, RNA was extracted using an RNeasy Kit (Qiagen, QIA74106) according to the manufacturers instructions
Common symptoms include: Chronic fatigue Dizziness or light-headedness Pale or yellowing skin Shortness of breath Mood swings, anxiety, or depression Tingling in hands and feet Brain fog or memory difficulties When these symptoms occur alongside hair loss, a B12 test is highly recommended
Delivery Methods and Dosing Strategies BPC-157 is used in both clinical and research settings via oral or injectable routes: Note: Dosing varies by patient weight, indication, and clinical supervision